12 Mar March 12, 2020 – Ascending Davos Meghan Fitzgerald, Eli Lilly Andy Vicari and CEO Action Sandro DiNello
“The audio file was removed when we switched hosts. Sorry. The cost was prohibitive. If you need the file, contact us and we will send it.”
Meghan Fitzgerald – Investor, Professor, Author and Board Member Healthcare
By 2032, we will have a shortage of 100,000 to 150,000
primary care physicians. I would love more dialog about
what we are doing about this.
Meghan Fitzgerald is an academic, investor, board member and global healthcare operator and strategist. A former nurse, she is now a Managing Partner at LetterOne Group, an international investment business with $25 billion of capital under management, where she runs the healthcare vertical for this fund. Her study on the health of executive women in the Fortune 500 was featured in the Harvard Business Review. Her new book is Ascending Davos: A Career Journey from the Emergency Room to the Boardroom. She began her career on the front lines of patient care before pivoting into strategic and operating roles throughout the Fortune 500 at companies like Merck, Pfizer, Medco Health Solutions and Cardinal Health. Today she is a managing partner in a $25B global private equity firm where she leads their healthcare investment strategies; an adjunct associate professor at Columbia University Mailman School of Public Health; and a board member for Tenet Health, Seniorlink, ABB Optical, K2 Health Ventures, and Destination Pet.
Andy Vicari – Senior Director & U.S. Brand Leader, Insulins, Eli Lilly and Company
Lilly has been doing as much as we can to make sure patients get their medication and that they have no need to ration or skip a dose.
Millions of Americans with high-deductible insurance plans are facing high out-of-pocket costs because their plans reset at the beginning of the year. Eli Lilly and Company is committed to helping those who face higher out-of-pocket costs afford their Lilly insulin. Launched in 2018, the Lilly Diabetes Solution Center is available to people who need help affording their Lilly insulin. Andy Vicari is Senior Director & U.S. Brand Leader for the Insulins portfolio at Eli Lilly and Company. In this role, Andy leads the brand teams in developing and executing cross-portfolio marketing strategies across various insulin brands at Lilly. Andy has held several leadership positions in sales and marketing. Outside of work, Andy serves on the Board of Directors for the American Diabetes Association.
Sandro DiNello – CEO of Flagstar Bank
It is our mission to get more and more companies to think about importance of diversity and inclusion.
This year, over 200 CEO Action signatory organizations are taking part in the second annual ‘Day of Understanding,’ an event created by CEO Action for Diversity & Inclusion™ (CEO Action) to help address potential bias in the workplace and help foster a culture of inclusion and understanding.